Page 20 - GPD-3-4
P. 20

Gene & Protein in Disease                                               Human sirtuins (SIRT1-7) in cancer



               inhibits bladder cancer growth by suppressing autophagy.   93.  Chen X, Xu Z, Zeng S,  et al. SIRT5 downregulation is
               Cell Div. 2023;18(1):9.                            associated with poor prognosis in glioblastoma.  Cancer
                                                                  Biomark. 2019;24(4):449-459.
               doi: 10.1186/s13008-023-00091-w
                                                                  doi: 10.3233/CBM-182197
            82.  Wang H, Li J, Huang R, Fang L, Yu S. SIRT4 and SIRT6 serve
               as novel prognostic biomarkers with competitive functions   94.  Yao L, Wang Y. Bioinformatic analysis of the effect of the
               in serous ovarian cancer. Front Genet. 2021;12:666630.  sirtuin family on differentiated thyroid carcinoma. Biomed
                                                                  Res Int. 2022;2022:5794118.
               doi: 10.3389/fgene.2021.666630
                                                                  doi: 10.1155/2022/5794118
            83.  Wang C, Liu Y, Zhu Y, Kong C. Functions of mammalian
               SIRT4 in cellular metabolism and research progress in   95.  Rizzo A, Iachettini S, Salvati E, et al. SIRT6 interacts with
               human cancer. Oncol Lett. 2020;20:11.              TRF2 and promotes its degradation in response to DNA
                                                                  damage. Nucleic Acids Res. 2017;45:1820-1834.
               doi: 10.3892/ol.2020.11872
                                                                  doi: 10.1093/nar/gkw1202
            84.  Min  Z,  Gao  J,  Yu  Y.  The  roles  of  mitochondrial  SIRT4  in
               cellular metabolism. Front Endocrinol (Lausanne). 2019;9:783.  96.  Mao Z, Hine C, Tian X, et al. SIRT6 promotes DNA repair
                                                                  under stress by activating PARP1. Science. 2011;332:1443-1446.
               doi: 10.3389/fendo.2018.00783
                                                                  doi: 10.1126/science.1202723
            85.  Cai G, Ge Z, Xu Y, Cai L, Sun P, Huang G. SIRT4 functions
               as a tumor suppressor during prostate cancer by inducing   97.  Tao NN, Ren JH, Tang H, et al. Deacetylation of Ku70 by
               apoptosis  and  inhibiting  glutamine  metabolism.  Sci   SIRT6 attenuates Bax-mediated apoptosis in hepatocellular
               Rep. 2022;12:12208.                                carcinoma. Biochem Biophys Res Commun. 2017;485:713-719.
               doi: 10.1038/s41598-022-16610-8                    doi: 10.1016/j.bbrc.2017.02.111
            86.  Bai W, Cheng L, Xiong L,  et al. Protein succinylation   98.  Chen W, Liu N, Zhang H,  et  al. Sirt6 promotes DNA
               associated with the progress of hepatocellular carcinoma.   end joining in iPSCs derived from old mice.  Cell
               J Cell Mol Med. 2022;26:5702-5712.                 Rep. 2017;18:2880-2892.
               doi: 10.1111/jcmm.17507                            doi: 10.1016/j.celrep.2017.02.082
            87.  Dai Y, Liu S, Li J, et al. SIRT4 suppresses the inflammatory   99.  Fiorentino F, Carafa V, Favale G, Altucci L, Mai A, Rotili  D.
               response and oxidative stress in osteoarthritis. Am J Transl   The two-faced role of SIRT6 in cancer.  Cancers (Basel).
               Res. 2020;12:1965-1975.                            2021;13:1156.
            88.  Wang K, Hu Z, Zhang C, et al. SIRT5 contributes to colorectal      doi: 10.3390/cancers13051156
               cancer growth by regulating T cell activity. J Immunol Res.   100. Sebastián C, Zwaans BM, Silberman DM, et al. The histone
               2020;2020:3792409.
                                                                  deacetylase SIRT6 is a tumor suppressor that controls cancer
               doi: 10.1155/2020/3792409                          metabolism. Cell. 2012;151(6):1185-1199.

            89.  Abril YLN, Fernandez IR, Hong JY, et al. Pharmacological      doi: 10.1016/j.cell.2012.10.047
               and  genetic  perturbation  establish  SIRT5  as  a  promising   101. Zhang ZG, Qin CY. Sirt6 suppresses hepatocellular carcinoma
               target in breast cancer. Oncogene. 2021;40(9):1644-1658.
                                                                  cell growth via inhibiting the extracellular signalregulated
               doi: 10.1038/s41388-020-01637-w                    kinase signaling pathway. Mol Med Rep. 2014;9(3):882-888.
            90.  Sun X, Wang S, Gai J,  et al. SIRT5 promotes cisplatin      doi: 10.3892/mmr.2013.1879
               resistance in ovarian cancer by suppressing DNA damage in   102.  Han Z, Liu L, Liu Y, Li S. Sirtuin SIRT6 suppresses cell
               a ROS-dependent manner via regulation of the Nrf2/HO-1   proliferation through inhibition of Twist1 expression in non-
               pathway. Front Oncol. 2019;9:754.
                                                                  small cell lung cancer. Int J Clin Exp Pathol. 2014;7(8):4774-81.
               doi: 10.3389/fonc.2019.00754
                                                               103. Bae JS, Noh SJ, Kim KM,  et al. SIRT6 is involved in the
            91.  Yan D, Franzini A, Pomicter AD, et al. SIRT5 is a druggable   progression of ovarian carcinomas via β-catenin-mediated
               metabolic vulnerability in acute myeloid leukemia.  Blood   epithelial to mesenchymal transition.  Front Oncol.
               Cancer Discov. 2021;2(3):266-287.                  2018;8:538.
               doi: 10.1158/2643-3230.BCD-20-0168                 doi: 10.3389/fonc.2018.00538
            92.  Fabbrizi E, Fiorentino F, Carafa V, Altucci L, Mai A, Rotili D.   104. Liu Y, Xie QR, Wang B, et al. Inhibition of SIRT6 in prostate
               Emerging roles of SIRT5 in metabolism, cancer, and SARS-  cancer reduces cell viability and increases sensitivity to
               CoV-2 infection. Cells. 2023;12:852.               chemotherapeutics. Protein Cell. 2013;4(9):702-710.
               doi: 10.3390/cells12060852                         doi: 10.1007/s13238-013-3054-5


            Volume 3 Issue 4 (2024)                         12                              doi: 10.36922/gpd.4100
   15   16   17   18   19   20   21   22   23   24   25